Does ketoconazole cause hair loss? This is a question many people ask when starting treatment with this widely used antifungal medicine. Ketoconazole is available in the UK primarily as a 2% shampoo for conditions such as dandruff, seborrhoeic dermatitis, and pityriasis versicolor. Whilst it is generally well tolerated, alopecia is listed as a possible adverse reaction in the product's official UK labelling. At the same time, some research suggests ketoconazole may actually support hair health by targeting scalp conditions that themselves cause shedding. This article explores the evidence, safety considerations, and what to do if you notice hair changes during treatment.

How Ketoconazole Works and Its Uses in the UK

Ketoconazole is an imidazole antifungal that inhibits ergosterol synthesis; in the UK it is primarily used as a 2% shampoo, as oral ketoconazole is now restricted to endogenous Cushing's syndrome following MHRA safety restrictions.

Ketoconazole is an antifungal medicine belonging to the imidazole class. It works by inhibiting the synthesis of ergosterol, a vital component of fungal cell membranes. Without ergosterol, fungal cells become structurally compromised and are unable to survive or replicate. This mechanism makes ketoconazole effective against a broad range of fungal and yeast infections.

In the UK, ketoconazole is available in several formulations, each licensed for specific indications:

• Topical shampoo (2%) — a Pharmacy (P) medicine available over the counter or on prescription, commonly used for dandruff, seborrhoeic dermatitis, and pityriasis versicolor

• Topical cream — used for localised fungal skin infections

• Oral tablets — use is now tightly restricted in the UK and EU; oral ketoconazole is no longer licensed for the treatment of fungal infections and is now only licensed for the management of endogenous Cushing's syndrome, under specialist supervision with regular liver-function monitoring

The MHRA issued a Drug Safety Update in 2013 restricting oral ketoconazole following a review of its liver safety profile, concluding that the risks of hepatotoxicity outweighed the benefits for fungal indications. The European Medicines Agency (EMA) subsequently approved oral ketoconazole (Ketoconazole HRA) solely for endogenous Cushing's syndrome. As a result, most patients in the UK encounter ketoconazole primarily in its topical forms. The shampoo formulation is widely used and generally considered safe when applied correctly and rinsed off thoroughly. Understanding how ketoconazole works helps contextualise any concerns about its potential effects on hair and the scalp.

The Link Between Ketoconazole and Hair Loss

Alopecia is a listed adverse reaction in the ketoconazole 2% shampoo SmPC, though it is rare; conversely, limited evidence suggests it may have a mild benefit in androgenetic alopecia, but this use remains off-label in the UK.

Experiencing these side effects? Our pharmacists can help you navigate them →

The question of whether ketoconazole causes hair loss requires careful consideration of the available evidence. It is important to note that alopecia (hair loss) is listed as a possible adverse reaction in the UK Summary of Product Characteristics (SmPC) and Patient Information Leaflet for ketoconazole 2% shampoo, albeit at an uncommon or unknown frequency. Patients should therefore be aware that hair loss can, in rare cases, be associated with its use.

At the same time, research has investigated ketoconazole shampoo as a potential adjunct in androgenetic alopecia (pattern hair loss). The proposed mechanism relates to ketoconazole's possible mild anti-androgenic properties — it has been hypothesised that it may reduce the influence of dihydrotestosterone (DHT) on scalp follicles, potentially slowing follicular miniaturisation. A small study published in the journal Dermatology (1998) reported improvements in hair density and follicle size in men with androgenetic alopecia using ketoconazole shampoo. However, this evidence is limited by small study sizes and indirect outcome measures, and this use remains off-label in the UK. The anti-androgenic mechanism is a hypothesis rather than an established fact, and patients should not use ketoconazole shampoo for hair loss without first discussing it with a healthcare professional.

For oral ketoconazole, systemic inhibition of adrenal and gonadal steroidogenesis is a recognised pharmacological effect. Significant hormonal disruption could theoretically influence the hair growth cycle, but oral ketoconazole is now prescribed only for Cushing's syndrome under specialist care, and such effects would be managed within that clinical context.

In summary, whilst topical ketoconazole is not a common cause of hair loss, alopecia is a recognised — if rare — adverse reaction. Any hair shedding during treatment should be assessed in the context of the underlying condition and other concurrent factors.

Not sure if this is normal? Chat with one of our pharmacists →

When Hair Shedding May Be a Side Effect

Hair shedding during ketoconazole use may be a direct adverse reaction or may reflect coincidental telogen effluvium or scalp irritation; stop use and consult a pharmacist or GP if shedding is significant or persistent.

As noted above, hair loss is listed as a possible adverse reaction in the ketoconazole 2% shampoo SmPC and PIL, though it is considered uncommon or of unknown frequency. Some individuals do report increased hair shedding during or after use, and it is important to distinguish between hair loss directly caused by the medication and hair changes that coincide with its use for other reasons.

Telogen effluvium is a common form of temporary hair shedding triggered by physiological stress, illness, nutritional deficiency, or hormonal changes. If a person begins using ketoconazole during a period of illness or stress, the shedding may be incorrectly attributed to the medication. This type of hair loss typically resolves once the underlying trigger is addressed.

In some individuals, scalp irritation from topical ketoconazole may occur, particularly in those with sensitive skin or if the product is used more frequently than recommended. Persistent scalp inflammation can contribute to hair fragility or shedding. Signs of scalp irritation to be aware of include:

• Redness or a burning sensation after application

• Increased scalp dryness or flaking

• Itching that worsens rather than improves with use

The product's instructions should be followed carefully — leaving shampoo on the scalp for longer than directed or using it excessively may increase the risk of local irritation.

If you experience significant hair shedding or persistent scalp irritation, stop using the product and seek advice from your pharmacist or GP before restarting. For those using ketoconazole as part of a prescribed course (for example, for pityriasis versicolor), do not discontinue without clinical guidance, as stopping prematurely may allow the underlying infection to recur.

If you develop signs of a severe allergic reaction — including facial or lip swelling, difficulty breathing, or widespread hives — call 999 or go to your nearest A&E immediately. For other urgent concerns, contact NHS 111 or your GP.

Conditions Ketoconazole Treats That Affect Hair Health

Seborrhoeic dermatitis and tinea capitis — both treated with ketoconazole — can themselves cause hair thinning or loss, meaning effective treatment often supports hair recovery rather than causing further damage.

Understanding the conditions for which ketoconazole is prescribed is essential, as several of these conditions can themselves cause or contribute to hair loss — independent of any medication effect.

Seborrhoeic dermatitis is one of the most common conditions treated with ketoconazole shampoo. It is caused by an overgrowth of the yeast Malassezia on the scalp and is characterised by flaking, redness, and itching. When severe or poorly controlled, seborrhoeic dermatitis can cause inflammation around hair follicles, potentially leading to temporary hair thinning or shedding. Treating the condition effectively with ketoconazole may therefore help to preserve hair density. NICE Clinical Knowledge Summaries (CKS) provide guidance on the management of scalp seborrhoeic dermatitis.

Tinea capitis (scalp ringworm) is a fungal infection that directly affects the hair shaft and follicle. It is more common in children and can cause patchy hair loss, scaling, and inflammation. If left untreated, it may result in scarring alopecia. Ketoconazole shampoo is used only as an adjunct to reduce spore shedding and is not curative as monotherapy — oral antifungal treatment is required. NICE CKS recommends oral terbinafine as first-line for Trichophyton species and griseofulvin for Microsporum species. Red-flag features of tinea capitis — including a kerion (boggy, tender, inflamed plaque), significant lymphadenopathy, or fever — warrant urgent GP or dermatology review to minimise the risk of scarring.

Pityriasis versicolor, caused by Malassezia species, primarily affects the trunk and does not typically cause hair loss, though it can occasionally affect the scalp.

In all these conditions, the hair changes observed are predominantly driven by the infection or inflammatory process itself, rather than by ketoconazole. Effective treatment generally supports hair recovery rather than hindering it.

What to Do If You Notice Hair Changes During Treatment

Assess whether shedding is diffuse or localised and consider recent triggers; contact your GP or pharmacist if hair loss is significant, rapid, or accompanied by scalp pain, and call 999 for severe allergic reactions.

If you notice changes in your hair or scalp whilst using ketoconazole, it is important not to panic but equally not to ignore persistent or worsening symptoms. A measured, stepwise approach is recommended.

First, assess the nature of the hair change:

• Is the shedding diffuse (all over the scalp) or localised to a specific area?

• Has the hair loss been gradual or sudden?

• Are there associated symptoms such as scalp redness, itching, or scaling?

• Have there been any recent stressors, illnesses, dietary changes, or new medications?

If the hair shedding is mild and you have recently started ketoconazole, it may be worth continuing treatment as directed whilst monitoring the situation. Many cases of mild shedding resolve spontaneously. However, you should contact your GP or pharmacist if:

• Hair loss is significant, rapid, or accompanied by scalp pain or visible bald patches

• Scalp irritation does not improve after reducing frequency of use

• You are using oral ketoconazole for Cushing's syndrome and notice any symptoms that may suggest liver problems, such as jaundice (yellowing of the skin or eyes), dark urine, or persistent nausea — contact your endocrinology team promptly, as routine liver-function monitoring is a standard part of this treatment

For severe allergic reactions — including difficulty breathing, swelling of the face, lips, or throat, or a widespread rash — call 999 or attend A&E immediately. For other urgent or same-day concerns, contact NHS 111.

Your GP may refer you to a dermatologist if the cause of hair loss is unclear or does not respond to initial management. Keeping a simple diary of symptoms, including when they started and any potential triggers, can be very helpful during a consultation.

MHRA Yellow Card Reporting and Treatment Alternatives

Suspected side effects from ketoconazole, including hair loss, should be reported via the MHRA Yellow Card scheme; alternatives for seborrhoeic dermatitis include selenium sulphide or zinc pyrithione shampoos, and licensed hair loss treatments include topical minoxidil and oral finasteride.

In the UK, patients and healthcare professionals are encouraged to report suspected side effects of any medicine — including ketoconazole — through the Yellow Card scheme, operated by the MHRA (Medicines and Healthcare products Regulatory Agency). Reports can be submitted online at yellowcard.mhra.gov.uk and play a vital role in ongoing drug safety monitoring. If you believe ketoconazole has caused or contributed to hair loss, submitting a Yellow Card report helps build the national evidence base, even if a causal link has not been formally established.

For those concerned about using ketoconazole, several alternatives exist depending on the underlying condition:

• Seborrhoeic dermatitis: Selenium sulphide shampoo, zinc pyrithione shampoo, or coal tar preparations are available over the counter. Topical corticosteroids may be prescribed for inflammatory flares. NICE CKS provides up-to-date guidance on management options.

• Tinea capitis: NICE CKS recommends oral terbinafine (for Trichophyton species) or griseofulvin (for Microsporum species) as first-line systemic treatments, with ketoconazole shampoo used adjunctively to reduce spore shedding.

• Androgenetic alopecia: Licensed treatments in the UK include topical minoxidil (available over the counter) and oral finasteride (on prescription for men). Ketoconazole shampoo is sometimes used off-label alongside these treatments, but evidence for this use is limited and it should only be considered following discussion with a healthcare professional. NICE CKS provides context on licensed options for androgenetic alopecia.

It is always advisable to discuss any concerns about your medication with your GP, pharmacist, or dermatologist before making changes to your treatment. Self-discontinuing antifungal therapy can lead to recurrence of infection and, in some cases, worsening of the scalp condition that may itself be contributing to hair changes. Evidence-based, personalised advice from a healthcare professional remains the safest course of action.

Frequently Asked Questions